Important: Vantelyx Labs products are sold strictly for research purposes only. Inquiry regarding human consumption is strictly prohibited.
Multi-pathway blend
KLOW
80 mg
A four-component research blend commonly formulated as GHK-Cu 50 mg, KPV 10 mg, BPC-157 10 mg and TB-500 10 mg for multi-pathway laboratory comparison work.
Contact for availability
Third Party COA tested. Please contact us for reports.
Research-use information only. Not presented for human or veterinary administration.
QUALITY ASSURANCE
Third-party COA testing
Third Party COA tested. Please contact us for reports.
ABOUT THE COMPOUND
Description & research context
KLOW is an industry designation for a multi-peptide research blend commonly combining GHK-Cu, KPV, BPC-157 and TB-500 in one vial. The format supports controlled comparison of convergent and parallel signalling routes within one experimental matrix.
APPLICATIONS IN RESEARCH
Common experimental themes
- Comparative multi-peptide signalling studies
- Copper-dependent and extracellular-matrix pathway work
- Melanocortin-linked KPV research
- BPC-157 cell-signalling and TB-500 cytoskeletal research
LABORATORY HANDLING
Handling & stability
- Handle under clean, dry laboratory conditions.
- Use an assay-appropriate vehicle according to the validated experimental protocol.
- Record batch, solvent, concentration and storage history for reproducibility.
- Minimise unnecessary freeze-thaw cycles after preparation.
RESEARCH NOTES
Interpretation & precautions
- Interpret results only within the model and assay being studied.
- Do not infer clinical or consumer outcomes from laboratory findings.
- For laboratory research use only.
REFERENCE READING